Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of the RIGHTEST Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes Mellitus

NCT04838392 is registered in ClinicalTrials.gov with Bionime Corporation as lead sponsor.

NCT NCT04838392
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04838392 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of the RIGHTEST Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes Mellitus
Lead sponsor
Bionime Corporation
Phase
Not applicable
Overall status
Unknown status
Start date
December 31, 2024
Completion date
November 30, 2025
Enrollment
150 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 1 diabetes, type 2 diabetes